Questcor Pharmaceuticals (QCOR +2.1%) trades higher after TheStreetSweeper issues the first part...

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR +2.1%) trades higher after TheStreetSweeper issues the first part of a much-anticipated 2-part report. In the report, which Questcor has already gone to great lengths to denounce, TheStreetSweeper accuses Questcor of marketing its Acthar drug for unsanctioned uses, and of failing to establish a "firewall" between its marketing and R&D departments.